Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Recruiting now

Conditions studied: Invasive Breast Cancer Early Stages

In brief

This is a multicenter, cohorts study to collect information from patients diagnosed with early-stage invasive breast cancer who have been previously included in a neoadjuvant or adjuvant clinical trial of the GEICAM group. Patients will be included in this study from the moment of completion of the follow-up of the studies of origin and will be followed for approximately 30 years

Key facts

Study ID
NCT03390894
Run by
Spanish Breast Cancer Research Group
People needed
8000
Starts
2018-01-18
Expected to finish
2048-01-01
Last updated by the study team
2025-05-14

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.